Echoes of old HIV paradigms: Reassessing the problem of engaging men in HIV testing and treatment through women's perspectives by Katirayi, Leila Georgena et al.
RESEARCH Open Access
Echoes of old HIV paradigms: reassessing
the problem of engaging men in HIV
testing and treatment through women’s
perspectives
Leila Katirayi1* , Addmore Chadambuka2, Auxilia Muchedzi2, Allan Ahimbisibwe3, Reuben Musarandega2,
Godfrey Woelk1, Thorkild Tylleskar4 and Karen Marie Moland4
Abstract
Background: With the introduction of 2016 World Health Organization guidelines recommending universal
antiretroviral therapy (ART), there has been increased recognition of the lack of men engaging in HIV testing
and treatment. Studies in sub-Saharan Africa indicate there have been challenges engaging men in HIV testing and
HIV-positive men into treatment.
Methods: This qualitative study explored women’s perspective of their male partner’s attitudes towards HIV and ART
and how it shapes woman’s experience with ART. Data were collected through in-depth interviews and focus group
discussions with HIV-positive pregnant and postpartum women on Option B+ and health care workers in Malawi and
Zimbabwe. In Malawi, 19 in-depth interviews and 12 focus group discussions were conducted from September–
December 2013. In Zimbabwe, 15 in-depth interviews and 21 focus-group discussions were conducted from July
2014–March 2014.
Results: The findings highlighted that many men discourage their partners from initiating or adhering to ART.
One of the main findings indicated that despite the many advancements in HIV care and ART regimens, there are
still many lingering negative beliefs about HIV and ART from the earlier days of the epidemic. In addition to existing
theories explaining men’s resistance to/absence in HIV testing and treatment as a threat to their masculinity or because
of female-focused health facilities, this paper argues that men’s aversion to HIV may be a result of old beliefs about HIV
and ART which have not been addressed.
Conclusions: Due to lack of accurate and up to date information about HIV and ART, many men discourage their female
partners from initiating and adhering to ART. The effect of lingering and outdated beliefs about HIV and ART needs to be
addressed through strengthened communication about developments in HIV care and treatment. Universal ART offers a
unique opportunity to curb the epidemic, but successful implementation of these new guidelines is dependent on ART
initiation and adherence by both women and men. Strengthening men’s understanding about HIV and ART will greatly
enhance women’s ability to initiate and adhere to ART and improve men’s health.
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Plain English summary
Many people face challenges starting and remaining on
antiretroviral treatment (ART), the medication recom-
mended for those with human immunodeficiency virus
(HIV). In sub-Saharan Africa, men greatly influence
their partner’s decisions, including decisions regarding
health care. This paper explores women’s perspective of
their male partner’s attitudes towards HIV and ART and
how it shapes woman’s experience with ART. Data were
collected using individual in-depth interviews and focus
group discussions of 6–12 people. Data were collected
with HIV-positive pregnant and postpartum women and
health care workers in two countries in sub-Saharan Af-
rica, Malawi and Zimbabwe. The findings highlighted
that across the study settings women commonly experi-
ence their male partners discouraging them from initiat-
ing and adhering to ART. One of the main findings
indicated that despite the many advancements in HIV
care and ART regimens, there are still many lingering
negative beliefs about HIV and ART from the earlier
days of the epidemic. This study argues that lack of ac-
curate information about HIV and ART may contribute
to male partners failing to engage in HIV testing and
treatment and supporting their female partner’s initi-
ation and adherence to ART. Hence, strengthening
men’s understanding about HIV and ART may greatly
enhance women’s ability to initiate and adhere to ART
and at the same time improve men’s health.
Background
HIV treatment in sub-Saharan Africa
Sub-Saharan Africa has witnessed an expansion in the
coverage of HIV antiretroviral treatment (ART) to rec-
ord numbers of people, increasing from 4.1 million in
2010 to 10.3 million 2015. Treatment coverage increased
from 24% in 2010 to 54% in 2015 [1]. A challenge to in-
creasing ART initiation is that only 45% [39–62%] of
people living with HIV in sub-Saharan Africa know their
HIV status. Within sub-Saharan Africa, 67% [65–68%] of
men and 57% [55–60%] of women living with HIV are
not receiving antiretroviral therapy [2].
Universal ART
Under the 2013 World Health Organization (WHO)
treatment guidelines, only those with a CD4 count less
than 500 cells/mm3 or WHO clinical stage 3/4 were
recommended to start ART [3]. However, the 2013
guidelines for prevention of mother-to-child HIV trans-
mission (PMTCT) recommended that all HIV-positive
pregnant and breastfeeding women initiate ART regard-
less of CD4 cell count or clinical stage for at least the
duration of mother-to-child transmission (MTCT) risk,
and in high HIV burden settings, initiate life-long ART
(referred to as “Option B+”). In September 2015, the
WHO released new recommendations, referred to as
“treatment for all” or “universal ART,” stating that ART
should be initiated in everyone living with HIV regard-
less of CD4 cell count or clinical stage [4]. In 2015, an
estimated 36.7 million people were living with HIV, with
17 million receiving ART [1]. With the new guidelines,
there is expected to be a significant increase in the num-
ber of people who will now be eligible for ART.
Universal ART falls under a concept labelled “Treat-
ment as Prevention” (TasP) which has become a driving
rationale for HIV policy [5]. Modelling studies have sug-
gested that expansion of ART coverage could be effective
in reducing transmission at the population level [6]. The
2015 WHO guidelines could change the face of the HIV
epidemic and significantly decrease HIV incidence,
depending on the success of ART uptake and retention.
Previous research has demonstrated challenges with ini-
tiating seemingly healthy (asymptomatic) individuals on
lifelong ART irrespective of their CD4 cell count. A study
in Canada found that 30.5% of HIV-positive patients opted
to defer ART, with the most common reason for delaying
ART among those with CD4 ≥ 500/mm3 cited as “no ur-
gency” or “no need for treatment” [7]. A study in Uganda
found that those who had been HIV-positive for some
time and had become eligible for ART under the new
“universal ART” guidelines were more likely to delay their
decision to start ART compared to those who were newly
diagnosed. The change in guidelines to universal ART
conflicted with the information they had previously re-
ceived regarding when to start ART. These participants
were proud of their ability to maintain a high CD4 count
and regarded delaying ART initiation as a major accom-
plishment [8]. At the time of writing, some countries have
begun implementing universal ART as national policy;
however, little is known about the effects of universal ART
on the social dynamics of disclosure processes, adherence
and retention [9].
Challenges engaging men in HIV testing and treatment
Universal ART guidelines will be the first effort to initi-
ate men on ART with CD4 ≥ 500/mm3. Previous studies
have demonstrated the challenges of getting men to ac-
cess health facilities, test for HIV and initiate and adhere
to ART [10–12]. Masculinity norms discourage men
from seeking care in an effort to ‘tough it out’ [13, 14].
Another challenge is that men view the health facility as
‘a woman’s domain’ making it uncomfortable for men to
access services [14].
Men are generally initiating ART much later and have
worse outcomes than women [15]. One study from South
Africa found that men had 4.4-higher odds of being un-
tested, and HIV-positive men had 1.8 and 1.6-higher odds
of being unaware of HIV status and untreated, respectively,
compared to women [16]. Previous studies have reported
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that men only access HIV services when in late stage dis-
ease [17–19]. More men in sub-Saharan Africa die from
acquired immunodeficiency syndrome (AIDS) than
women, despite women having higher HIV prevalence
than men [10]. As stated in a paper by Dovel, “AIDS
prevalence may have the face of a woman, but AIDS
mortality has the face of a man” ([10], page 1).
With the history of male reluctance to undergo HIV
testing and receive treatment, there is an urgent need to
tailor programs to the needs of men. Hence, focusing on
the role of men, this paper aims to identify the lessons
learned from implementation of lifelong ART under Op-
tion B+ to inform the scaling up of universal ART. HIV-
positive women’s experiences with their male partners is
used an entry point to understand the challenges of HIV
testing and treatment and how men affect their partner’s
ability to initiate and adhere to ART.
Methods
Study design
This descriptive qualitative study in Malawi and Zimbabwe
collected data using in-depth interviews (IDIs) and focus
group discussions (FGDs) to explore the acceptability of
initiating lifelong ART with pregnant and breastfeeding
women. As the first country to pilot Option B+, Malawi
was selected for the study. Zimbabwe was selected as a
comparative case for its interest in assessing the acceptabil-
ity of Option B+ at pilot sites. The study was initially con-
ducted in Malawi in 2013 and then modified for
Zimbabwe’s context and conducted in Zimbabwe in 2014.
Results from Malawi have been published [20]. The primary
focus of the studies in Malawi and Zimbabwe was the
acceptability of Option B+. During analysis it was discov-
ered that both data sets had in-depth information about
women’s perspectives about their male partners’ attitudes
towards HIV and ART. This data provided a unique oppor-
tunity to explore how women understand and interpret
men’s attitudes towards HIV and ART and how it shapes
the woman’s experience with ART. Results illustrating the
challenges and fears experienced by men as perceived by
the pregnant and postpartum partners and the influence of
the male partner on women’s ability to initiate and adhere
to ART are presented here. While the study was conducted
in different contexts, findings were very similar and there-
fore have been combined in this paper to strengthen the
transferability of the results. Comparing the results of the
two country contexts drew attention to the challenges men
are facing to engage in HIV testing and treatment. The find-
ings would be most applicable in a low-income setting, with
a patriarchal society and over-stressed health care systems.
Study population
In both Malawi and Zimbabwe, the study population
was comprised of pregnant and postpartum women
initiated on Option B+ and health care workers (HCWs)
who provided PMTCT services. Pregnant women were
at least 18 years of age, HIV-positive, receiving the ART
regimen associated with Option B+ and receiving ante-
natal care (ANC) from one of the selected study sites.
Postpartum women met the same selection criteria in
addition to having delivered and breastfed a child within
the last 18 months. HCWs had to have worked in the se-
lected health care facilities for the previous six months
providing maternal and child health services, including
PMTCT.
Site selection
In Malawi, four health care facilities were selected as the
study sites. The districts of Lilongwe, Dedza and Mchinji
were purposively selected for their rural, urban and peri-
urban settings. In addition, different facility types includ-
ing government-owned (free services) or privately-
owned (pay-for services) were selected. Within these pa-
rameters, the sites with the highest volume of HIV-
positive pregnant women were selected.
In Zimbabwe, the urban and rural districts of Harare
and Zvimba were selected based on their relatively close
proximity to the city of Harare. Once the districts were
chosen, eight public health facilities (free services) with
the highest annual volume of HIV-positive pregnant
women were selected.
Malawi & Zimbabwe setting
Malawi and Zimbabwe share similar characteristics of
predominantly patriarchal societies where the male part-
ner is considered the ‘head of the house’ and women’s
ability to make decisions for themselves or family is lim-
ited [21, 22]. In a study in Malawi and Zimbabwe partic-
ipants reported the wife is supposed to be seen as ‘silent,
subordinate and submissive.’ “Culture says that she has
to be submissive because the head of the house is a
man, he is the breadwinner, he takes care of the family.
No decision can be made without consulting the man,
so she is in a submissive kind of situation.” (p.182) [23].
Male dominant attitudes limit a woman’s choices about
her sexuality, use of contraception, decisions around
having children, the welfare of her and the children and
control over household finances and resources [24].
Malawi and Zimbabwe have similar population sizes,
Malawi has a population of approximately 18,300,000
and Zimbabwe a population of approximately 16,300,000
[25]. Malawi has nine main ethnic groups while
Zimbabwe is more homogenous with two primary ethnic
groups. Both Malawi and Zimbabwe are predominantly
Christian. Malawi has a higher fertility rate of 4.9 chil-
dren per woman, compared to 3.7 children per woman
in Zimbabwe [26].
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Malawi has an adult (15–49 years) HIV prevalence of
10.0% [27]. Zimbabwe has an adult HIV prevalence of
14.7% [28]. In Zimbabwe, the HIV prevalence among
pregnant women 15–49 years has declined from 16.1% in
2009 to 15.9% in 2012 [29]. In 2010 in Malawi, the HIV
prevalence among HIV-positive pregnant women was re-
ported to be 10.6% [30]. In both countries eight of ten
HIV-positive pregnant women access ART [28, 31]. In
2015 Malawi saw an estimated 4800 new infections among
children, while Zimbabwe had an estimated 4900. In 2015,
approximately 15,000 women acquired HIV in Malawi
compared 32,000 women in Zimbabwe. According to the
UNAIDS 2016 estimates, the overall MTCT rate is re-
ported to be 9% in Malawi [31] and 7% in Zimbabwe [28].
Data collection
Data were collected in Malawi during September –
December 2013 and in Zimbabwe from July 2014–
March 2015 with trained research assistants (RAs).
Reflexivity was discussed during the data collection
training and RAs were trained to reflect upon their
pre-understanding of the study topic areas and how
that could influence how they asked questions and se-
lected follow-up questions, potentially introducing
bias. Pregnant and postpartum women were selected
using convenience sampling, they were recruited as
they arrived at the health facility. HCWs identified
eligible women and referred them to onsite RAs.
Pregnant and post-partum women participated in both
IDIs and FGDs, while HCWs only participated in FGDs.
Eligible HCWs were identified by the nurse in-charge
and referred to the RAs. All eligible HCWs were invited
to participate in FGDs in both Malawi and Zimbabwe.
All study participants voluntarily agreed and signed writ-
ten informed consent forms. Confidentiality was dis-
cussed during the informed consent process and at the
beginning of the FGDs.
The data collection tools used in Malawi were adapted
to fit the Zimbabwe context. Both versions of the data
collection tools for the pregnant and postpartum women
focused on the following: understanding general percep-
tions towards lifelong ART; messages provided at the
clinic by HCWs; perspectives in the community; barriers
and facilitators to initiating and adhering to ART; male
involvement; disclosure, and support received. The FGD
guides for the HCW asked about aforementioned items
in addition to asking about the HCW’s preparation and
attitudes towards providing Option B+. Single inter-
viewers conducted the IDIs; a moderator with a note-
taker conducted the FGDs which consisted of 6–12
participants. IDIs with pregnant and postpartum women
took approximately 65 minutes , FGDs with pregnant
and postpartum women averaged two hours and FGDs
with HCWs averaged two hours and 35 minutes. In
Malawi data were collected in the local language of Chi-
chewa, and Zimbabwe data was collected in the local
language of Shona (although some FGDs with HCWs
were conducted in English). All IDIs and FGDs were
audio-recorded to ensure that the data were accurately
captured without subjective filtering of information.
Audio-recordings were simultaneously transcribed and
translated, including descriptions of the participant’s
body language and non-verbal response. The study co-
ordinator reviewed approximately 10% of the transcripts
while listening to the audio-recording to ensure the
translations were accurate.
Data analysis
Data from the studies conducted in Malawi and
Zimbabwe were analyzed separately using thematic ana-
lysis. All transcripts were entered into MAXqda v.10.
Transcripts were reviewed by the study team, and a code
list representative of the findings was created. The code
lists were circulated among each study team, including
the in-country staff to ensure that it accurately reflected
the data. The code list was updated several times based
on feedback. Related codes were grouped into overarch-
ing themes. Data were analyzed by study population.
Data reduction and summary tables were created to
organize the results and track the emergence of themes
from the data. Results from both countries that focused
on women's perspectives of men’s attitude towards HIV
testing and treatment and how men influenced their
partner’s ART initiation and adherence were reviewed
using the data reduction and summary tables and code
reports. Quotes were selected from both countries to il-
lustrate thematic findings.
Ethical considerations
Ethical approval was received in Malawi from the Malawi
Ministry of Health National Health Sciences Research
Committee. In Zimbabwe, the study received ethical ap-
proval from the Medical Research Council of Zimbabwe.
Results
Study population
In Malawi, a total of 19 IDIs were conducted with pregnant
women and 20 with postpartum women. Four FGDs were
conducted with HCWs, four FGDs with pregnant women
and four FGDs with postpartum women. In Zimbabwe 15
IDIs were conducted with pregnant women and 19 IDIs
were conducted with postpartum women. Four FGDs were
conducted with HCWs, eight FGDs with pregnant women
and nine FGDs with postpartum women.
In both countries, the majority of participants were
married. The mean age for women in Malawi was 28.3
and 28.8 years in Zimbabwe. In Malawi, most participat-
ing women had completed primary education, while in
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Zimbabwe most participating women had completed sec-
ondary education (Table 1). In Malawi and Zimbabwe,
most HCWs had 1–10 years of experience. In Malawi, the
majority of HCWs were nurses, while in Zimbabwe only
nurses participated in the study (Table 2).
Findings
The results have been organized into five main themes:
men’s reluctance to know and share their HIV diagnosis;
pretending to be HIV-negative; lacking male spaces; men’s
powerful influence on their partner’s ART adherence; and
lingering beliefs about HIV and ART (Table 3).
Men’s reluctance to know and share their HIV diagnosis
In both Zimbabwe and Malawi, men’s lack of knowledge
about HIV was repeatedly mentioned as linked to fear of
HIV testing. Some women attributed men’s lack of
knowledge to men not utilizing the health facility, as it is
mostly women who attend the facility for antenatal care.
Women felt that the lack of knowledge was a significant
challenge and mentioned the need for the men to be ed-
ucated on HIV and ART.
“The messages that are given, to me it’s not
enough, because it targets the woman who is
pregnant, I wish men who are responsible for the
pregnancies could also be taught, because if they
are not taught, they won’t be concerned at all,
especially when it comes to sex, or even reminding
their partners to take the medication. They don’t
care because they don’t know anything about that,
and the day they are angered, they will harass you
because of the medication, because they don’t have
knowledge.” (Zimbabwe, lactating woman)
“Husbands should have their part to receive
counseling because marriages are ending because a
woman is receiving medicine and the husband is not
accepting because it is difficult for a man to accept a
thing from a woman.” (Malawi, lactating)
It was commonly reported in both Zimbabwe and
Malawi that men refused to get tested for HIV even
when feeling ill. Men avoided getting tested for HIV
even when visiting the health facility.
“ …even at the time I told him that he must go and
get tested he was very difficult even when he is sick
and you tell him to go to the hospital he refuses”
(Malawi, lactating woman)
“The day that I got tested for HIV I had given
birth already and the nurse said when he comes
to bring you food, tell him that the nurses want
to talk to him. I told him and he sneaked away
from the ward, running away from seeing the
nurse. He drove his car and went away. So, from
that day he does not want to hear about it.”
(Zimbabwe, lactating woman).
Women said that some men had stated that there was
no need for them to be tested for HIV; they would deter-
mine their HIV status based on their partner’s status.
The belief that one’s HIV status can be determined by
another’s reflects a lack of knowledge and a determin-
ation to avoid testing oneself for HIV.
“Some men just say when the woman gets tested
whatever status they are told; for instance, if she is
found to be HIV positive, then he says I am also
HIV positive and if found to be HIV negative, then
he says he is also negative. This is what he says and
there is no way to argue with him.” (Zimbabwe,
lactating woman)















< 25 9 (24%) 23 (24%) 10 (14%) 25 (26%)
25–34 22 (58%) 59 (63%) 54 (77%) 57 (59%)
35–44 7 (18%) 12 (13%) 6 (9%) 14 (15%)
Married/Cohabitating 34 (89%) 74 (89%) 65 (93%) 86 (90%)
Single/Divorced/Widow 4 (11%) 20 (11%) 5 (7%) 10 (10%)
No education 5 (13%) 15 (16%) 4 (6%) 2 (2%)
Primary 22 (58%) 51 (54%) 19 (27%) 26 (27%)
Secondary 11 (29%) 27 (29%)a 47 (67%) 68 (71%)
aFor Malawi postpartum, one woman was missing education level
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Pretending to be ‘HIV-negative’
While many women reported that their male partner re-
fused to engage in HIV testing, women in both countries
reported believing that their male partners knew their
HIV status but chose to keep it a secret until the woman
learned her HIV status. Study participants reported that
their partners knew they were HIV-positive but failed to
disclose their results.
“In my case, it appears my husband got tested for
HIV first and he got to know his status but he did
not disclose to me. So, when I got pregnant, got
tested for HIV and disclosed my status to him, he
responded well and said to me it’s common [to be
HIV-positive] and told me to initiate ART but he
does not want to be on ART.”
(Zimbabwe, Lactating woman)
“You know, this is my first marriage but my husband
has been married before. I suppose that is where he
got HIV infected. I only discovered much later that he
was positive because of my visit to the clinic. Otherwise
I would have died of HIV without ever knowing I was
HIV positive. These men can be so heartless and
deceiving.” (Malawi, pregnant woman)
Some women believed that their male partners had
tested positive for HIV and had been secretly taking
antiretroviral drugs (ARVs).
“Men are taking their medication secretly, without
their wives knowing because the man pretends to
be negative until he convinces his wife to get tested,
knowing that he is infected. So men are the most
cunning ones.” (Zimbabwe, lactating woman)
“I saw that there was medicine in the house but I
didn’t know they were ARVs because I don’t know
how to read. I just thought he’s getting medicine from
the hospital for some problem. He didn’t tell me he
was HIV-positive. I suppose he knew I would find out
eventually on my own at the hospital. The time I was
beginning the process of getting my ARVs, he had
already been taking them for a whole year.”
(Malawi, pregnant)
While there were several cases of women reporting that
their partner was secretly taking ART, it was more com-
monly reported that men refuse to initiate ART after
learning that they are HIV-positive.
“Haa, my husband was not accepting that we were
HIV positive, he was denying it, and he did not
take medication until his death.” (Zimbabwe,
lactating woman)
Lack of male spaces
Participants spoke frequently about the need to educate
men about HIV and ART. Some participants stated that
there was the need for more “male friendly” services to
engage and educate men.
“ …the main problem which they [men] said was that
our hospital is not male friendly, when they have come
we don’t have a place to leave them… when they have
come to the hospital we put them on the line singing
with women which we cannot do” (Malawi, HCW).
A Zimbabwean participant suggested creating a special space
for men where they would be comfortable receiving services.
“Create a men’s corner where men can gather and have
conversations while waiting for their women. This would
also be a place where the men can be given instruction
or education on HIV. Men need to be instructed on why
and how to take the medication and to remind their
partners.” (Zimbabwe, pregnant or postpartum).
Some participants recommended more male HCWs are
needed to work with the men.
Table 2 Demographic characteristics for the participating
health care workers
Health Care Workers
in Malawi N = 43
n (%)
Health Care Workers
In Zimbabwe N = 25
n (%)
Age (in years)
< 25 0 1 (4)
25–34 19 (44) 6 (24)
35–44 15 (35) 14 (56)
45+ 9 (21) 4 (16)
Level of qualification (Malawi)
ART Clerk 3 (7) –
Nurse 27 (63) –
Clinical Officer 6 (14) –
HSAa 4 (9) –
Medical Assistant 2 (5) –
Counselor (Zimbabwe) 1 (2) –
Primary Nurse – 15 (60)
General Nurse – 9 (36)
Community Nurse – 1 (4)
Years in current position
1–5 11 (26) 9 (36)
6–10 13 (30) 10 (40)
11+ 19 (44) 6 (24)
aHealth Surveillance Assistant
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“More male health workers are needed to talk to
the men. Culturally, for women to talk to men it is
misconstrued to be women challenging men. If a
man speaks to fellow men they can listen.”
(Zimbabwe, postpartum)
Men’s powerful influence on their partner’s ART
adherence
References were made in both Malawi and Zimbabwe
about the man being the head of the house and having the
final say in all decisions regarding his partner and family.
“I think women have a burden because of the setup
and culture of Malawi that a woman cannot do a
thing on her own when her husband did not accept
it. She is not an independent…” (Malawi, HCW).
“I think it has more to do with cultural issues and the
roles that we play at home as men. According to our
culture the men is the head of the household
therefore he has the power to make all the decisions,
so he does what he wants” (Zimbabwe, HCW)
Because men have the power in their household to de-
termine women’s health care, their lack of knowledge
about HIV and ART greatly affects their partner’s ability
to initiate and adhere to ART. Women often demon-
strate a commitment to initiate and adhere to ART, but
men may discourage or prevent their partners from initi-
ating and adhering to ART.
“I met a certain woman, she tested HIV-positive… and
attended antenatal very well, but didn’t take the medicine,
she tried explaining to her husband who is a Reverend
[religious position] but he told her not to take the
medicine they will just pray for her… the woman
was more willing to start but failed because of the
husband. We tried to give her options like the
medicine but she said her husband searches everywhere…
he checks her bags to see what she brought from the
hospital” (Malawi, HCWs)
Religion has been documented as both a barrier and fa-
cilitator to ART adherence. Some religious leaders claim
that prayer can cure HIV and that drugs should not be
taken. This quote highlights religion as a barrier and the
fact that a woman’s partner has the power to determine
whether she can take her medication.
Some women reported receiving incorrect advice from
their partners encouraging them to stop their medica-
tion. Given men’s lack of information about ART, men
may be confused and advise their partner incorrectly.
“… When we went home after receiving counseling
he said that, ‘you have the liberty to stop taking the
medicine once you have given birth.’ But when I
called my mother because my mother is a nurse she
said that’s not true…” (Malawi, pregnant woman)
Partners were also viewed as a facilitator to ART initiation
and adherence. While, women frequently discussed their
partner as a barrier to ART initiation and adherence, some
women reported that their partner was supportive of them
being on ART, provided emotional support and helped to
remind them to take their medication.
“…my husband is supportive, he encourages me to
take lifelong ARVs and always asks me about the
appointment date to receive the drugs and make
sure he follows that day and reminds me to come
and collect the drugs” (Malawi, lactating woman)
Some participants reported receiving support from their
HIV discordant partner.
Table 3 Summary of findings
Men’s reluctance to know and share their HIV diagnosis
• Women felt that men need more information about the benefits of
HIV
testing
• Men refused to receive HIV tests even when feeling unwell or
partner was HIV-positive
• Men want to “test by proxy” and determine their HIV status based
on their partner’s status
Pretending to be HIV negative
• If men do learn their HIV status, they often keep it a secret
• A few women reported that their partners hid their HIV status and
secretly took ART
• The majority of women reported that even if their partner learned
their HIV status they would still refuse ART
Lacking male spaces
• Participants claimed that men do not access the health facility
because they view it as a ‘female space’ and are not comfortable
accessing services there
• Participants recommended creating a separate space for men at the
facility
• Some participants recommend having more male HCWs available
to speak with the men
Men’s powerful influence on their partner’s ART adherence
• Men often discouraged or prevented their partners from initiating
or adhering to ART
• Some men provided incorrect information about ART to their
female partners
• Some women reported that their partners were supportive and
helped remind them to take ART
Lingering beliefs about HIV and ART
• There were many lingering beliefs in the community about HIV
being a death sentence and a lack of messages about the ability to
live a long and healthy life on ART
• Previously ART was for those who had low CD4 counts and were
very ill. The idea that ART is only for the very ill remains in the
community
• Many people are not aware of the developments in ART and
believe that ART is still a complicated multi-pill regimen
• Many fear the side effect of being disfigured, that was associated
with drugs used in the older ART regimens
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“We were both tested for HIV and he tested negative
and I tested positive. He was not disturbed much at
that time because the counsellors sat down with us
and taught us. When we got home, it was me who
got stressed and I even lost weight. He was even
encouraging me to take my medicine and warning
me against defaulting, saying if I default, I will die.
He would wake up, cook for me and giving me my
medicine to take. Even after I gave birth, he knows
what time to give medicine to our baby. Before he
goes to work, he makes sure he gives our baby
medicine.” (Zimbabwe, lactating woman)
Partner’s support was one of the main factors determin-
ing ART initiation and adherence. Many of the issues
women discussed with their own initiation and adher-
ence were related to their partner’s support or refusal of
them taking ART. HCWs in both countries reported that
engaging the men was crucial to improving women’s
ART initiation and adherence.
“… we should involve men because if we are involving
the whole family it means the woman has support so
that the woman should initiate ART without any
challenges.” (HCW)
Lingering beliefs about HIV and ART
Throughout the data, it was found that beliefs about
HIV and ART from earlier days in the HIV epidemic
have not changed despite advancements in HIV care
and treatment. Study participants described beliefs they
had heard in the community such as HIV is a death sen-
tence, ART is only for very sick people, and ART is a
complicated multi-drug regimen. The lack of knowledge
about the developments in HIV care and treatment high-
light a clear gap in how communities are being informed
and educated about changing public health practices.
Many women discussed old sentiments about HIV being
a death sentence in the community. These kinds of beliefs
were prevalent in both countries and deterred both women
and men from initiating and adhering to treatment.
“…the husband was refusing to take the medicine and
asked why he should bother taking the medicine when
this disease has come for the people [implying death].”
(Malawi, HCW)
It was also clear that the association between HIV and
death was strong:
“I was afraid because I listened to what people were
saying”, that “you die, you die”, but when I took the
medication I realized that it was not true and I
accepted it [ART] well (Zimbabwe, lactating woman)
In both Zimbabwe and Malawi there were many precon-
ceived notions that ART was only for the very ill and
therefore those who “felt healthy” reported challenges
initiating ART.
“For some, they take the medicine and just leave them
without drinking them because they feel good in their
bodies [implying feeling healthy]. But for those who
see that their bodies are weak and they are found
positive, that’s the time they take the medicine.”
(Malawi, pregnant woman)
For most men, if they don’t feel any pain, they will
tell you that they are not HIV positive. For instance,
my husband says it’s me who is ill and not him. So,
he says to me “take your ARVs, I will only take ARVs
when I am bed ridden.” But this is a problem to me
because my wish is for both of us to be on ART but
he insists that he is not ill. (Zimbabwe, lactating
woman)
Ideas of ART being for the very ill have also continued
to linger through images used at the health facility.
Some women commented on the visual depictions at the
facility indicating that ART is for the very ill.
“…we entered in a room and HCWs started showing us
pictures; the first picture was for a person who was very
sick and malnourished before she started ARVs but
when she went for HIV testing and started taking the
medicine she was improving…” (Malawi, lactating woman)
One of the most challenging aspects of earlier HIV care
was the large cocktail of drugs required multiple times a
day. The shift of ART regimens under Option B+ from
an ART regimen requiring multiple daily pills to a regi-
men with one daily pill has been encouraging for many.
“My husband has colleagues that he works with who
initiated ART some time ago and they were taking
many tablets at a time. My husband used to comment
saying if he was to test HIV positive, he would be
happy to hear that he can wait a little while before
initiating ART because of the burden of taking many
tablets at a time. Now, he accepts it more because
people on ART are now taking just one tablet a day.”
(Zimbabwe, lactating woman)
Those who are utilizing the facility, such as pregnant and
postpartum women, have the opportunity to learn about
advancements in HIV care and treatment. Those who
don’t access the facility or have other means of becoming
informed (such as having a partner in antenatal care) may
not be aware of these new developments.
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In both Malawi and Zimbabwe concerns of side-
effects from the drugs resulting in disfiguration were
mentioned. Stavudine was a drug used in earlier ART
regimens which caused disfiguration; however, it has not
been communicated widely to the public that this drug
is no longer in use.
“It was just hearsay from people who started early
days that when a person is taking the ARVs she
becomes so bumpy in her head, not attractive face,
muscles like weight lifters and many things, pimple
on the face, ladies hips goes away but when I started
there was no such signs which I saw.” (Malawi,
lactating woman)
Discussion
The results highlight many challenges with men accept-
ing HIV testing and treatment and the powerful influ-
ence that men have on their partner’s ability to initiate
and adhere to ART. While WHO guidelines recommend
that all people diagnosed as HIV-positive initiate ART,
there are many challenges that need to be overcome
first.
Reduction of HIV transmission on a population level
requires successful acceptance of ART by the communi-
ties to which these new guidelines are targeted. Fully un-
derstanding men’s challenges with HIV testing and
treatment is critical to optimize universal ART and en-
sure initiation and adherence of ART.
Two primary theories have emerged to explain why
men do not engage in HIV testing and treatment. The first
theory suggests that HIV testing and treatment threatens
traditional norms of masculinity [19, 32]. The second the-
ory hypothesizes that health services have been designed
for women, and men have been systematically left out
[10]. These theories are also influenced by contextual bar-
riers including poverty, stigma and distrustful and difficult
relationships with HCWs [33]. The findings of this study
build on these two theories and provide an additional per-
spective; that outdated beliefs about HIV care and treat-
ment deter men from engaging in HIV testing and
treatment. Outdated beliefs such as HIV is a death sen-
tence, ART is only for the very ill, ART is a complicated,
multi-drug regimen with visible side-effects and the lack
of knowledge that one can live a long healthy life on ART
discourage men from initiating HIV testing and treatment
and supporting their partners.
Fear of loss of masculinity
Connell defines ‘hegemonic masculinity’ as a social norm
both created and reinforced by society [34]. Hegemonic
masculinity has been associated with men having multiple
sexual partners, being viewed as powerful, risk takers, pro-
viders and tough in the face of illness [35]. Study
participants reported that men seemed fearful of HIV and
ART and would refuse to be tested. The fear of receiving a
HIV test is well documented in the literature, with previ-
ous studies highlighting fears of loss of masculinity, power,
and pride with an HIV-positive test result [11, 17]. Partici-
pants reported that even when their male partner was very
ill they would still refuse to attend the facility to receive a
HIV test or start treatment. Local notions of masculinity
disfavor seeking help because it is thought to be a sign of
weakness [36, 37]. As a result, men often wait to access
the health facility until they are very ill [37].
According to the women and HCWs interviewed, men
want to avoid being tested for HIV and potentially re-
ceiving a HIV-positive diagnosis. HIV is associated with
being weak, vulnerable, and requiring help [17]. This as-
sociation discourages men from getting tested for HIV
[38]. Data from both Malawi and Zimbabwe found that
men claimed a HIV test was not necessary since they
could infer their HIV status from their partner. Diag-
nosis by “proxy” is well documented in the literature [19,
37]. On the other hand, some men may learn their HIV
status and keep it a secret to avoid threatening their
masculinity [17]. This study found that if men do learn
their HIV status they may attempt to keep it secret and
they may also start treatment secretly to avoid admitting
illness and therefore weakness. By dismissing their
health needs and taking physical risks, men are legitim-
izing themselves as the “stronger” sex [39].
Study participants reported that their male partners
who either tested HIV-positive or strongly suspected a
HIV-positive diagnosis refused to initiate ART. Receiving
treatment and being dependent on others can threaten a
man’s masculinity [32]. The women in this study reported
that not only did men not want to initiate ART them-
selves, they also discouraged or prevented their partner
from taking ART. Previous literature has discussed how
men may seek to control their partner and their partner’s
actions (such as taking medication) as a means to assert
power and therefore reinforce an image of masculinity
[32]. HCWs providing female partners with health infor-
mation (which men may not have access to) creates an
element of being excluded and therefore feeling out of
control. Study participants reported that their partners
were often uneducated about HIV and ART, and partici-
pants wished the health care messages would target men
or include men in the counseling.
Female centric health care system
The second main theory explaining men’s aversion to
HIV testing and treatment postulates that the health
facility has been designed to care for women, and men’s
health care needs have been neglected. This theory
hypothesizes that men’s poor health and poor health
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seeking behaviors are a result of the female-centric
health care system that has left men out [10].
Study participants reported that men do not feel com-
fortable at the facility and feel that it is a woman’s space.
Clinics are seen to be “female spaces” [17, 37]. A study
in South Africa found that men felt that that they did
not belong at the health facility, and the study empha-
sized the need for men to learn about HIV in a “safe
space” in which men could talk with one another and
listen to experiences of other men [40]. Study partici-
pants also discussed the need for a male friendly space.
One study in South Africa found that a man who is
seen seeking care at a health facility could lead to gossip
about HIV status, since men do not have the same rea-
sons as women (i.e. pregnancy) for being seen when
healthy [36]. Such perceptions about the health facility
may deter men from accessing the facility, which is
where the majority of the population receives HIV tests.
ART is also provided at the health facility, and again the
female dominated space may discourage men from
accessing treatment.
A study in South Africa found that male dominated
spaces such as health facilities servicing truck stop
drivers and men working in the mining industry were
more successful in engaging men [36]. One study in
South Africa found that mobile, population wide testing
via community health campaigns and home-based HIV
testing reduced but did not eliminate barriers to male
engagement in mobile community HIV testing [37].
New research has shown that testing at home with self-
test kits is well accepted by men, however, this is a fairly
new practice [37].
While these two theories offer different perspectives,
they are also highly interconnected, as utilizing a ‘female
space’ may threaten a man’s masculinity and deter him
from utilizing the health facility. Both theories contrib-
ute to understanding men’s challenges engaging in HIV
testing and treatment; however, they are insufficient to
fully explain men’s aversion to HIV and ART.
Echoes of the old art paradigm
Throughout this study and the literature, men’s fear of
HIV is well documented. Kurt Riezler argues that fear
may be shaped by ignorance [41] and this is particularly
relevant in the context of HIV. Many men exhibit a lack
of knowledge regarding HIV and ART [38]. This war-
rants a deeper examination, are men’s apprehensions to-
wards HIV testing and treatment rooted in lack of
information and education about the new developments
in HIV care? While there has been tremendous progress
in the ability for one to live a long and healthy life on
ART and significant developments in simplification of
ART, data from this study demonstrates lack of informa-
tion about these developments among men and the
community at large. This raises the question of whether
men are rejecting HIV testing and treatment based on
old associations of HIV and ART and what are effective
means of communicating and engaging with men.
Results from this study show that many of the earlier
truths about HIV and ART continue to persist. Old ideas
of HIV as a death sentence continue to linger and beliefs
such as these continue to discourage men from success-
fully engaging in HIV testing and treatment [11, 38].
Fear of visible side effects from the earlier drug regimens
(primarily stavudine) were documented in this study and
have been seen in other literature [42]. Study partici-
pants indicated that men have only learned about the
simplified drug regimen from others on ART and that
this information has not been shared widely in the com-
munity. Beliefs that ART is only for ‘very sick people’
continue to linger despite recent guidelines recommend-
ing that all HIV-positive people initiate ART irrespective
of a CD4 count or clinical staging. Such beliefs may pre-
vent men from engaging in HIV testing and treatment.
Previous research has documented husband's interfere
with their partner's adherence to ART [32]. In response
to men’s attitudes towards HIV and ART, some women
may choose to keep their HIV status a secret. However,
failure to disclose one’s HIV status has been associated
with poor adherence to ART [43].
In both countries, study participants spoke frequently
about the need to further educate men about HIV and
ART. Men lack information about living positively with
HIV and the benefits of ART. Strengthening men’s ac-
ceptance of HIV testing and treatment will not only
strengthen the men’s health, but it will also address
women’s HIV vulnerability and enhance overall health
outcomes in women [38].
Many efforts to increase uptake of HIV testing and
treatment have focused on populations as a whole with-
out paying attention to the specific needs and concerns
of different populations within communities. Literature
has documented that interventions are most successful
when tailored and targeted to specific groups within the
community [9]. Messages about HIV testing and ART need
to target men and address their specific needs and concerns
in places where men feel comfortable [19]. Previous re-
search has indicated men’s interest in receiving information
in a male dominated environment, from male HCWs, in
the privacy of their homes and through information di-
rected at them (not via their partners) [17, 18, 38].
In addition to providing accurate information about
HIV and ART, there is a need to address gender norms,
which discourages men from seeking health services and
supporting their partners. Masculinity norms can be
interpreted as a positive resource and be built upon in an
HIV prevention context. Gender transformation programs
such as the South African One Man Can or Stepping
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Stones [40, 44] aim to shift masculinity norms to encour-
age men to support their partner’s health as well as be an
active agent in their own health care. Because gender
norms are created and reinforced within the community
by both men and women, these norms must be addressed
not only at the individual level, but also at the community
level. A study in Uganda highlighted how norms of mas-
culinity can encourage receipt of HIV care and treatment,
since it enabled HIV-positive men to feel strong, healthy
and continue to work and provide for their family [45].
These gender transformation programs highlight agency
and the ability for individuals and groups to redefine their
masculinity. As Connell has contended there are different
masculinities [34]. Different groups will have different in-
terpretations of what masculinity is. It’s critical therefore
to examine and address masculinity norms which under-
mine HIV testing and treatment within their social and
cultural context.
Limitations
The main strength of this study is the triangulation of
the findings between different country contexts and dif-
ferent types of study participants. Similar findings from
different country contexts increases the transferability of
study results. Triangulating data from different types of
study participants and comparing responses increases
the validity of the results. The study had several limita-
tions. The primary limitation is that no data were col-
lected directly with men, all reports of men’s opinions
and behaviors were reported from female study partici-
pants and HCWs. There are limitations to understand-
ing one group’s beliefs and attitudes through another
group’s interpretation. However, women's perspectives
may provide more candor into men's fear of HIV and
critical insight into how men influence women’s ART
initiation and adherence. Another major limitation was
the fact that women who participated in the study were
recruited directly from the health facility and had initi-
ated ART. Thus, the population does not include more
vulnerable populations of women who may not have ac-
cess to a health facility, who rejected Option B+, whose
child did not live or who were unable to breastfeed their
child. A final limitation was the simultaneous transcrip-
tion and translation of the data, translating the data first
and then transcribing reduces chances of interpretation
errors.
Conclusion
While universal ART has many benefits for individual
health and aims to decrease the general HIV epidemic
with treatment as prevention, there are many challenges
that need to be overcome first. This study found that
one of the primary barriers to women initiating and ad-
hering to ART were their male partners. Fear of loss of
masculinity and challenges accessing a female-centric fa-
cility are key factors that contribute to men’s aversion to
engaging in HIV care and treatment. Outdated beliefs
about HIV and ART also discourage men from utilizing
HIV testing and treatment services. More information
about HIV and ART is needed at the community level,
and targeted towards the different community members,
specifically men. Providing HIV testing and treatment
services in male friendly spaces or at home may encour-
age men to accept HIV testing and treatment. Universal
ART offers a unique opportunity to curb the epidemic,
but successful implementation of these new guidelines is
dependent on ART initiation and adherence by both
women and men.
Abbreviations
AIDS: Acquired immunodeficiency syndrome; ANC: Antenatal care;
ART: Antiretroviral therapy; ARV: Antiretroviral drug; CD4: Cluster of
differentiation 4; FGD: Focus group discussion; HCW: Health care worker;
HIV: Human immunodeficiency virus; IDI: In-depth interview; MTCT: Mother-
to-child transmission; PMTCT: Prevention of mother-to-child transmission;
RA: Research assistant; TasP: Treatment as prevention; WHO: World Health
Organization
Acknowledgements
We offer our sincere appreciation to the health care workers and clients at
the selected facilities that made this study possible. We would also like to
acknowledge both the Malawi Ministry of Health and Zimbabwe Ministry
of Health and Child Welfare for working with the Elizabeth Glaser Pediatric
AIDS Foundation to conduct this important study in the health facilities. In
addition, we would like to thank the University of California Los Angeles
Pediatric AIDS Coalition for the funding raised through the Dance Marathon
which supported the study in Malawi.
Funding
The data collected in Zimbabwe was funded under the Children’s
Investment Fund Foundation program grant “Accelerating the Elimination
of Paediatric HIV/AIDS”, and the funder had no role in study design, data
collection and analysis, decision to publish or preparation of the manuscript.
The data collected in Malawi was funded by the University of California Los
Angeles Pediatric AIDS Coalition for the funding raised through the Dance
Marathon, and the funder had no role in study design, data collection and
analysis, decision to publish or preparation of the manuscript.
Availability of data and materials
Data will not be shared due to confidentiality concerns, particularly the small
sample and ability to trace responses back to individual respondents.
Authors’ contributions
Conceived the research: LK, AC, AM. Designed study: LK, AC, AM. Analysis
and interpretation of data: LK, AC, AM, KMM, TT. Wrote the paper: LK, KMM,
TT. All authors have read approved the last version of the manuscript.
Ethics approval and consent to participate
The data collected in Malawi received ethical approval from the National
Health Science Research Committee. The approval number is NHSRC #1157.
The data collected in Zimbabwe received ethical approval from the Medical




The authors declare that they have no competing interests.
Katirayi et al. Reproductive Health  (2017) 14:124 Page 11 of 13
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published
maps and institutional affiliations.
Author details
1Elizabeth Glaser Pediatric AIDS Foundation, 1140 Ave NW, Suite 200,
Washington, D.C, CT 20036, USA. 2Elizabeth Glaser Pediatric AIDS Foundation,
Harare, Zimbabwe. 3Elizabeth Glaser Pediatric AIDS Foundation, Lilongwe,
Malawi. 4Center for International Health/CISMAC (Centre for Intervention
Science in Maternal and Child Health), University of Bergen, Bergen, Norway.
Received: 9 May 2017 Accepted: 20 September 2017
References
1. UNAIDS Global Update. Geneva. 2016. http://www.unaids.org/sites/default/
files/media_asset/global-AIDS-update-2016_en.pdf Accessed on 22 Nov 16.
2. UNAIDS. Gap report. Geneva. http://files.unaids.org/en/media/unaids/
contentassets/documents/unaidspublication/2014/UNAIDS_Gap_report_en.
pdf Accessed on 22 Nov 16
3. World Health Organization. Consolidated guidelines on the use of
antiretroviral drugs for treating and preventing HIV infection –
recommendations for a public health approach June 2013. Geneva. http://
www.who.int/hiv/pub/guidelines/arv2013/en Accessed on 22 Nov 16
4. World Health Organization. Guidelines on when to start antiretroviral therapy
and on pre-exposure prophylaxis for HIV. Geneva; 2015. http://apps.who.int/
iris/bitstream/10665/186275/1/9789241509565_eng.pdf Accessed 12 Feb 16
5. Bond V, Hoddinott G, Viljoen L, Simuyaba M, Musheke M, Seeley J. Good
health and moral responsibility: Key concepts underlying the interpretation
of treatment as prevention in South Africa and Zambia before rolling out
universal HIV testing and treatment. AIDS Patient Care STDs. 2016;30
(9):425–34. doi: 10.1089/apc.2016.0114.
6. Vernooij E, Mehlo M, Hardon A, Reis R. Access for all: contextualizing HIV
treatments as prevention in Swaziland. AIDS Care. 2016;28(3):7–13.
7. Hoehn N, Gill MJ, Krentz HB. Understanding the delay in starting
antiretroviral therapy despite recent guidelines for HIV patients retained
in care. AIDS Care. 2016;18:1–6. doi: 10.1080/09540121.2016.1234678.
8. Mbonye M, Seeley J, Nalugya R, Kiwanuka T, Bagiire D, Mugyenyi M, et al.
Test and treat: the early experiences in a clinic serving women at high risk
of HIV infection in Kampala. AIDS Care. 2016;28(3):33–8.
9. Maeri I, Ayadi A, Getahun M, Charlebois E, Akatukwasa C, Tumwezbaze D, et
al. “How can I tell?” Consequences of HIV status disclosure among couples
in eastern African communities in the context of an ongoing “test-and-
treat” trial. AIDS Care. 2016;28(3):59–66.
10. Dovel K, Yeatman S, Watkins S, Poulin M. Men’s heightened risk of AIDS-
related death: the legacy of gendered HIV testing and treatment strategies.
AIDS. 2015;29(10):1123–5.
11. Mambanga P, Sirwali R, Tshitangano T. Factors contributing to men’s
reluctance to seek HIV counseling and testing at Primary Health Care
facilities in Vhembe District of South Africa. Afr J Prm Health Care Fam Med.
2016;8(2):A996.
12. Shand T, Thomson-de Boor H, Van den Berg W, Peacock D, Pascoe L. The
HIV Blind spot: Men and HIV testing, treatment and care in sub-Saharan
Africa. IDS Bull. 2014;45:1.
13. Stern E, Rau A, Cooper D. Sexual and reproductive health perceptions and
practices as revealed in the sexual history narratives of South African men
living in a time of HIV/AIDS. Sahara-J: Journal of Social Aspects of HIV/AIDS.
2014;11(1):233–44.
14. Colvin C, Robins S, Leavens J. Grounding Responsibilization Talk:
Masculinities, Citizenship and HIV in Cape Town, South Africa. J Dev Stud.
2010;46(7):1179–95.
15. Mills E, Beyrer C, Birungi J, Dybul M. Engaging men in prevention and care
for HIV/AIDS in Africa. PLoS Med. 2012;9(2):e1001167.
16. Huerga H, Van Cutsem G, Farhat JB, Reid M, Bouhenia M, Maman D, et al.
Who needs to be targeted for HIV testing and treatment in KwaZulu-Natal?
Results from a population-based survey. JAIDS. 2016;73(4):411–8.
17. Skovdal M, Madenhire C, Mupambireyi Z, Nyamukapa C. Masculinity as a
barrier to men’s use of HIV services in Zimbabwe. Glob Health. 2011;7:13.
18. Orr N, Hajiyiannis H, Myers L, Makhubele M, Matekane T, Delate R, et al.
Development of a national campaign addressing South African men’s fears
about HIV counseling and testing and antiretroviral treatment. JAIDS. 2017;
74(1):S69–73.
19. Chikovore J, Gillespie N, McGrath N, Orne-Glieman J, Zuma T, TasP study
group. Men, masculinity, and engagement with treatment as prevention in
KwaZulu-Natal, South Africa. AIDS Care. 2016;28(sup 3):74–82.
20. Katirayi L, Namadingo H, Phiri M, Bobrow EA, Ahimbisibwe A, Berhan AY, et
al. HIV-positive pregnant and postpartum women’s perspectives about
Option B+ in Malawi: a qualitative study. J Int AIDS Soc. 2016;19:20919.
21. Gipson J, Muntifering C, Chauwa F, Taulo F, Tsui A, Hindin M. Assessing the
importance of gender roles in couples’ home-based sexual health services
in Malawi. African Journal of AIDS Research. 2010;14(4 0 0):61–71.
22. Montgomery E, Chidanyika A, Chipato T, Van der Straten A. Sharing the
trousers: gender roles and relationships in an HIV-prevention trial in
Zimbabwe. Culture, Health & Sexuality. 2012;17(7):795–810.
23. Woodsong C, Alleman P. Sexual pleasure, gender power and microbicide
acceptability in Zimbabwe and Malawi. AIDS Educ Prev. 2008;20(2):171–87.
24. O’Brien S, Broom A. Gender, culture and changing attitudes: experiences of
HIV in Zimbabwe. Culture, Health & Sexuality. 2013;15(5):583–97.
25. World Population Review Zimbabwe. (2016). Accessed 19 Mar 2017, from
http://worldpopulationreview.com/countries/zimbabwe-population/
26. World Population Review, Malawi. (2016). Accessed 19 Mar 2017, from
http://worldpopulationreview.com/countries/malawi-population/
27. ICAP. Malawi population-based HIV impact assessment (MPHIA) 2016: ICAP;
2016. http://phia.icap.columbia.edu/wp-content/uploads/2016/09/MALAWI-
Factsheet.FIN_.pdf
28. UNAIDS Factsheet Zimbabwe. UNAIDS, Geneva. Accessed on 7 Feb 2017.
http://www.unaids.org/sites/default/files/media/documents/UNAIDS_
GlobalplanCountryfactsheet_zimbabwe_en.pdf
29. Ministry of Health (MoH), Zimbabwe. Zimbabwe national survey of HIV and
syphilis prevalence among women attending antenatal clinics in Zimbabwe,
2012. Harare: AIDS & TB Programme; 2013. http://catalogue.safaids.net/sites/
default/files/publications/ANC%20sero-surveillance%202013.
pdf%20national%20survey%20of%20HIV%20AND%20SYPHILIS.pdf Accessed
on 19 Feb 2017
30. UNAIDS. Global AIDS Response Progress Report (GARPR). Malawi Progress
Report for 2013. Government of Malawi. Published on March 31st 2014.
http://files.unaids.org/en/dataanalysis/knowyourresponse/
countryprogressreports/2014countries/MWI_narrative_report_2014.pdf
Accessed on 22 Nov 2016.
31. UNAIDS Factsheet Malawi. UNAIDS, Geneva. Accessed on 7 Feb 2017.
http://www.unaids.org/sites/default/files/media/documents/UNAIDS_
GlobalplanCountryfactsheet_malawi_en.pdf
32. Skovdal M, Campbell C, Nyamukapa C, Gregson S. When masculinity
interferes with women’s treatment of HIV infection: a qualitative study
about adherence to antiretroviral therapy in Zimbabwe. J Int AIDS Soc.
2011;14:29.
33. Stern E, Colvin C, Gxabagxaba N, Schutz C, Burton R, Meintjes G.
Conceptions of agency and constraint for HIV-positive patients and
healthcare workers to support long-term engagement with antiretroviral
therapy in Khayelitsha. African Journal of AIDS Research. 2017;16(1):19–29.
34. Connell RW. Hegemonic masculinity, rethinking the concept. Gender &
Society. 2006;19(6):829–59.
35. Stern E, Pascoe L, Shand T, Richmond S. Lessons learned from engaging men in
sexual and reproductive health as clients, partners and advocates of change in
the Hoima district of Uganda. Culture, Health & Sexuality. 2015;17(S2):S190–205.
36. Treves-Kagan S, Steward WT, Ntswane L, Haller R, Gilvydis J, Gulati H, et al.
Why increasing availability of ART is not enough: a rapid, community-based
study on how HIV-related stigma impacts engagement to care in rural
South Africa. BMC Public Health. 2016;16:87. doi: 10.1186/s12889-016-2753-2.
37. Camlin C, Ssemmondo E, Chamie G, El Ayadi A, Kwarisiima D, Sang N, et al.
Men “missing” from population-based HIV testing: insights from qualitative
research. AIDS Care. 2016;28(3):67–73.
38. DiCarlo A, Mantell J, Reimen R, Zerbe A, Morris D, Pitt B, et al. ‘Men usually
say that HIV testing is for women’: Gender dynamics & perceptions of HIV
testing in Lesotho. Culture Health & Sexuality. 2014;16(8):867–82.
39. Courtenay W. Constructions of masculinity and their influence on men’s
well-being: a theory of gender and health. Soc Sci Med, 50. 2000:1385–401.
40. Fleming P, Colvin C, Peacock D, Dworkin S. What role can gender-
transformative programming for men play in increasing men’s HIV testing
and engagement in HIV care and treatment in South Africa? Culture, Health
& Sexuality. 18(11):1251–64.
Katirayi et al. Reproductive Health  (2017) 14:124 Page 12 of 13
41. Riezler K. The Social Psychology of Fear. Am J Sociol. 1944;49(6):489–98.
http://www.jstor.org/stable/2771546
42. Finkelstein JL, Gala P, Rochford R, Glesby MJ, Mehta S. HIV/AIDS and
lipodystrophy: implications for clinical management in resource-limited
settings. J Int AIDS Soc. 2015;18(1):19033.
43. Heestermans T, Browne J, Aitken S, Vervoort S, Klipstein-Grobusch K.
Determinants of adherence to antiretroviral therapy among HIV-positive
adults in sub-Saharan Africa: a systematic review. BMJ Global Health. 2016;
1(4):e000125. doi: 10.1136/bmjgh-2016-000125.
44. Skevington SM, Sovetkina EC, Gillison FB. A systematic review to
quantitatively evaluate ‘Stepping Stones’: a participatory community-based
HIV/AIDS prevention intervention. AIDS & Behavior. 2013;17(3):1025–39.
45. Siu GE, Seeley J, Wight D. Dividuality, masculine respectability and
reputation: how masculinity affects men’s uptake of HIV treatment in rural
Eastern Uganda. Soc Sci Med. 2013;89:45–52.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Katirayi et al. Reproductive Health  (2017) 14:124 Page 13 of 13
